441
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Clinical aspects of ALS in Gulf War Veterans

, , , , , , , , & show all
Pages 35-41 | Received 28 Apr 2008, Published online: 10 Jul 2009

References

  • Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003; 61: 742–9
  • Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B. Are amyotrophic lateral sclerosis patients cognitively normal?. Neurology. 2003; 60: 1094–7
  • Gordon P, Moore D, Miller RG, Florence J, Verheijde J, Doorish C, et al. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomized trial. Lancet Neurology. 2007; 6: 1045–53
  • McGuire V, Longstreth WT, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996; 47: 571–3
  • Juvarra G, Bettoni L, Bortone E, Garavelli A, Montanari E, Rocca M. Amyotrophic lateral sclerosis in the province of Parma, Italy: a clinical and epidemiological study in the period 1960–1980. Ital J Neurol Sci 1983; 4: 473–8
  • Rosati G, Pinna L, Granieri E, Aiello I, Tola R, Agnetti V, et al. Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, southern Italy. Acta Neurol Scand. 1977; 55: 231–44
  • Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, et al. The natural history of amyotrophic lateral sclerosis. Neurology. 1993; 43: 1316–22
  • Eisen A, Schulzer M, Macneil M, Pant B, Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve. 1993; 16: 27–32
  • Caroscio JT. In: Rose FC,Research Progress in Motor Neurone Disease. London: Pitman; 1984. pp 34–43.
  • Albert SM, Murphy PL, Del Bene ML, Rowland LP. Prospective study of palliative care in ALS: choice, timing, outcomes. J Neurol Sci. 1999; 169: 108–13
  • Marti-Fabregas J, Pradas J, Illa I. Prognostic factors in amyotrophic lateral sclerosis. Neurologia. 1996; 11: 174–81
  • Boman K, Meurman T. Prognosis of amyotrophic lateral sclerosis. Acta Neurol Scand. 1967; 43: 489–98
  • Gross-Paju K, Oopik M, Luus SM, Kalbe I, Puksa L, Lepik T, et al. Motor neuron disease in south Estonia. Diagnosis and incidence rate. Acta Neurol Scand. 1998; 98: 22–8
  • Norris F, Shepherd R, Denys E, Mukai KUE, Elias L, Holden D, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci. 1993; 118: 48–55
  • Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland,1995–1997. A population-based study. Neurology 1999; 52: 504–9
  • Tysnes OB, Vollset SE, Aarli JA. Epidemiology of amyotrophic lateral sclerosis in Hordaland County, western Norway. Acta Neurol Scand. 1991; 83: 280–5
  • Guidetti D, Bondavalli M, Sabadini R, Marcello N, Vinceti M, Cavalletti S, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology. 1996; 15: 301–12
  • Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome. Neurology. 2002; 59: 99–103
  • Bracco L, Antuono P, Amaducci L. Study of epidemiological and etiological factors of amyotrophic lateral sclerosis in the province of Florence, Italy. Acta Neurol Scand. 1979; 60: 112–24
  • Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996; 15: 239–45
  • Kristensen O, Melgaard B. Motor neuron disease: prognosis and epidemiology. Acta Neurol Scand. 1977; 56: 299–308
  • Olivares L, Esteban ES, Alter M. Mexican'resistance' to amyotrophic lateral sclerosis. Arch Neurol. 1972; 27: 397–402
  • Hojer-Pedersen E, Christensen PB, Jensen NB. Incidence and prevalence of motor neuron disease in two Danish counties. Neuroepidemiology. 1989; 8: 151–9
  • Granieri E, Carreras M, Tola R, Paolino E, Tralli G, Eleopra R, et al. Motor neuron disease in the province of Ferrara, Italy, in 1964–1982. Neurology 1982; 38: 1604–8
  • Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003; 60: 683–9
  • Lorez A. A contribution on the clinical aspects and incidence of amyotrophic lateral sclerosis. (Isolated and familial cases). Schweiz Med Wochenschr. 1969; 99: 51–7
  • Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand. 1983; 68: 20–9
  • Salemi G, Fierro B, Arcara A, Cassata M, Castiglione MG, Savettieri G. Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study. Ital J Neurol Sci. 1989; 10: 505–9
  • Christensen PB, Hojer-Pedersen E, Jensen NB. Survival of patients with amyotrophic lateral sclerosis in two Danish counties. Neurology. 1990; 40: 600–4
  • Scarpa M, Colombo A, Panzetti P, Sorgato P. Epidemiology of amyotrophic lateral sclerosis in the province of Modena, Italy. Influence of environmental exposure to lead. Acta Neurol Scand. 1988; 77: 456–60
  • Preux PM, Couratier P, Boutros Toni F, Salle JY, Tabaraud F, Bernet Bernady P, et al. Survival prediction in sporadic amyotrophic lateral sclerosis: age and clinical form at onset are independent risk factors. Neuroepidemiology. 1996; 15: 153–60
  • Holloway SM, Mitchell JD. Motor neuron disease in the Lothian region of Scotland 1961–81. J Epidemiol Community Health 1986; 40: 344–50
  • Turner MR, Bakker M, Sham P, Shaw CE, Leigh PN, Al-Chalabi A. Prognostic modeling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002; 3: 15–21
  • Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999; 53: 1059–63
  • Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve. 2002; 25: 709–14
  • Rosen AD. Amyotrophic lateral sclerosis: clinical features and prognosis. Arch Neurol. 1978; 35: 638–42
  • Bettoni L, Bazzani M, Bortone E, Dascola I, Pisani E, Mancia D. Steadiness of amyotrophic lateral sclerosis in the province of Parma, Italy,1960–1990. Acta Neurol Scand 1994; 90: 276–80
  • Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68: 1002–7
  • Chio A, Bottacchi E, Buffa C, Mutani R, Mora G. Positive effects of tertiary centers for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006; 77: 948–50
  • McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis: the role of psychological factors. Arch Neurol. 1997; 51: 17–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.